Real-time enrollment status for this solid tumors clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:42 PM UTC
| NCT Number | NCT06431594 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 675 participants |
| Active Locations | 18 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | June 25, 2026 (Jun 25, 2026) |
As of October 12, 2026: Clinical trial NCT06431594 is currently recruiting participants. This phase1 study for solid tumors is actively seeking new participants at 18 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06431594 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06431594 was last updated Jun 25, 2026 (June 25, 2026). HelloStudys verifies this status automatically.